Davos Alzheimer's Collaborative Healthcare System Preparedness to Increase Cognitive Assessment Rates for Older Adults
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
In this study the investigators explore a pragmatic strategy to increase cognitive screening rates in the community. The investigators will compare the monetary value of different combinations of SCD questionnaires, digital cognitive tests, and blood Alzheimer's Disease (AD) biomarkers to identify the best approach for primary care settings.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: t
View:
• age 65 years or older
Locations
Other Locations
Germany
Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums
RECRUITING
München
Contact Information
Primary
Dr. Kurz
Psy.Alzheimerzentrum@med.uni-muenchen.de
+4989440055863
Time Frame
Start Date: 2023-02-01
Estimated Completion Date: 2024-02-01
Participants
Target number of participants: 500
Treatments
Other: Subjective Cognitive Decline Questionnaire (SCD-Q)/no other procedure
Participants will undergo procedure as usual and fill out the questionnaire SCD-Q
Other: SCD-Q + digital cognitive testing using Cognigram
Participants will undergo procedure as usual with their GP, additionally they will fill out the SCD-Q and undergo cognitive testing (Cognigram)
Other: SCD-Q + Cognigram + blood-based biomarkers
Participants will undergo procedure as usual with their GP, additionally they will fill out the SCD-Q and undergo cognitive testing (Cognigram). The blood-based biomarkers will be determined.
Related Therapeutic Areas
Sponsors
Collaborators: ki:elements, University of Southern California, Hoffmann-La Roche, Johanniter-Unfall-Hilfe e.V., Eisai Limited
Leads: Ludwig-Maximilians - University of Munich